Investigation looking into abuse of Israeli drugmaker's dominant market position; pharmaceutical company was sued in the US for price-fixing of same medicine
Tentative agreement comes hours ahead of federal trial with allegations that distributors failed to stop suspicious orders of drugs from being shipped despite warnings of misuse
Israeli generic drug manufacturer named as 'consistent participant' in conspiracies to raise prices, sometimes by more than 1000%; executives said to have obstructed investigation
Recent comments